首页 | 本学科首页   官方微博 | 高级检索  
     

黄芪精口服液防治小儿反复呼吸道感染的临床观察
引用本文:杨善浦,董虹,吴月超,苏华,吴叶健,黄爱萍. 黄芪精口服液防治小儿反复呼吸道感染的临床观察[J]. 中国中西医结合杂志, 2008, 28(6): 544-547
作者姓名:杨善浦  董虹  吴月超  苏华  吴叶健  黄爱萍
作者单位:浙江省玉环县人民医院,浙江,317600
摘    要:目的 观察黄芪精口服液防治小儿反复呼吸道感染(RRI)的临床疗效和对免疫功能的影响。

关 键 词:黄芪精口服液;反复呼吸道感染;T细胞亚群;免疫球蛋
修稿时间:2007-09-19

Clinical Effect of Milkvetch Extract Oral Liquid in Preventing and Treating Children's Recurrent Respiratory Tract Infection
YANG Shan-pu,DONG Hong,WU Yue-chao. Clinical Effect of Milkvetch Extract Oral Liquid in Preventing and Treating Children's Recurrent Respiratory Tract Infection[J]. Chinese journal of integrated traditional and Western medicine, 2008, 28(6): 544-547
Authors:YANG Shan-pu  DONG Hong  WU Yue-chao
Affiliation:People's Hospital of Yuhuan County, Zhejiang. yuhuanysp@yahoo.com.cn
Abstract:OBJECTIVE: To explore and compare the clinical effects of three immuno-potentiators and their influence on immune function in preventing and treating recurrent respiratory tract infection (RRI). METHODS: Seventy-two children with RRT were assigned to three groups, the 23 patients in the M group treated with milkvetch extract oral liquid, the 23 in the P group treated by P-transfer factor and the 26 in the U group treated by Utilins injection. Clinical effect was compared among three groups after treatment, and changes of T cell subgroups as well as immune antibodies were detected before and after treatment. RESULTS: The markedly effective rate in the M, P, and U group was 69.6%, 65.2%, and 73.0% respectively, and the total effective rate 87.0%, 82.6%, and 92.3%, showing an insignificant difference among them (all P>0.05). After treatment, the levels of CD3+, CD4+ and CD4+/CD8+ rose obviously in the three groups (all P<0.05); levels of CD8+ in the M group and the P group lowered significantly (P<0.05, P<0.01), but with no significant difference among three groups in the changes of T cell subgroups (all P>0.05). Serum levels of IgG in all the three groups, IgA in the P group and the M group, and IgM in the M group and the U group rose significantly (P<0.05 or P<0.01), with statistical difference presented in comparing of IgA level in the P group with that in the other two groups (P<0.01). CONCLUSION: The clinical effects and the outcomes of immunological indexes' changing are similar in RRI patients treated by the three immuno-potentiators. They all can enhance the immunological function of the organism, strengthen the disease-resistant ability of patients, and reduce the incidence of RRI. Among them, the milkvetch extract oral liquid is worthy of spreading due to its lower cost, simple administration, exemption from painful injection, and good compliance.
Keywords:milkvetch extract oral liquid  recurrent respiratory tract infection  T lymphocyte subgroup  immunoglobulin
本文献已被 维普 万方数据 等数据库收录!
点击此处可从《中国中西医结合杂志》浏览原始摘要信息
点击此处可从《中国中西医结合杂志》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号